nps-568 has been researched along with Disease Models, Animal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Eren, B; Güleç, İ; Karacan, M; Karagöz-Güzey, F; Önay-Uçar, E; Özcan, TB; Şengelen, A; Vahabova, G | 1 |
| Batlle, D; Harris, PC; Somlo, S; Torres, VE; Wang, X | 1 |
| Ben-Dov, IZ; Naveh-Many, T; Nechama, M; Silver, J | 1 |
| Chen, NX; Chen, X; Duan, D; Gattone, VH; Henley, C; Martin, D; Moe, SM; Seifert, MF; Sinders, RM | 1 |
| Chen, NX; Duan, D; Gattone, VH; Henley, C; Martin, D; Moe, SM; Seifert, MF; Sinders, RM | 1 |
| Torres, VE | 1 |
| Bacallao, RL; Chen, NX; Chen, X; Eggleston-Gulyas, T; Gattone, VH; Herbert, BS; Hoffmeyer, WD; Moe, SM | 1 |
| Dong, H; Fernandez, RA; Guo, Q; Makino, A; Pohl, NM; Smith, KA; Yamamura, A; Yamamura, H; Yuan, JX; Zeifman, A; Zimnicka, AM | 1 |
| Akizawa, T; Hatamura, I; Kinugasa, E; Koshikawa, S; Mizobuchi, M; Negi, S; Ogata, H; Saji, F; Sakaguchi, T; Shiizaki, K; Uda, S | 1 |
| Akizawa, T; Hatamura, I; Kinugasa, E; Mizobuchi, M; Negi, S; Ogata, H; Saji, F; Sato, T; Shibata, M; Shiizaki, K | 1 |
| Gohlke, P; Hadtstein, C; Nakagawa, K; Odenwald, T; Ritz, E; Roesch, F; Schaefer, F; Schmitt, CP | 1 |
| Aguilera-Tejero, E; Almaden, Y; Lopez, I; Martin, D; Mendoza, FJ; Perez, J; Rodriguez, M | 1 |
| Berger, I; Geldyyev, A; Gross, ML; Kokeny, G; Koleganova, N; Nakagawa, K; Piecha, G; Ritz, E; Schmitt, CP | 1 |
| Furuya, Y; Ishii, H; Kobayashi, N; Miyata, S; Nagano, N; Sakiyama, J; Wada, M | 1 |
| Fox, J; Furuya, Y; Ishii, H; Nagano, N; Nemeth, EF; Wada, M | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
16 other study(ies) available for nps-568 and Disease Models, Animal
| Article | Year |
|---|---|
The calcimimetic R-568 attenuates subarachnoid hemorrhage-induced vasospasm through PI3K/Akt/eNOS signaling pathway in the rat model.
Topics: Animals; Calcimimetic Agents; Disease Models, Animal; Male; Nitric Oxide Synthase Type III; Phenethylamines; Phosphatidylinositol 3-Kinases; Propylamines; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2021 |
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
Topics: Aniline Compounds; Animals; Aquaporin 2; Calcium; Cyclic AMP; Disease Models, Animal; Female; Humans; Kidney; Male; Mice; Mice, Knockout; Mice, Mutant Strains; Phenethylamines; Polycystic Kidney, Autosomal Dominant; Polycystic Kidney, Autosomal Recessive; Propylamines; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Rats, Mutant Strains; Receptors, Calcium-Sensing; Receptors, Vasopressin; RNA, Messenger | 2009 |
Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
Topics: 3' Untranslated Regions; Adenine; Aniline Compounds; Animals; Calcium; Chronic Disease; Disease Models, Animal; Half-Life; Hyperparathyroidism, Secondary; Kidney Diseases; Lanthanum; Male; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Phosphates; Phosphorus, Dietary; Propylamines; Rats; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Time Factors; Trans-Activators | 2009 |
R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
Topics: Aniline Compounds; Animals; Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Hyperparathyroidism; Male; Minerals; Phenethylamines; Polycystic Kidney, Autosomal Dominant; Propylamines; Rats; Rats, Sprague-Dawley | 2009 |
Calcimimetic inhibits late-stage cyst growth in ADPKD.
Topics: Aniline Compounds; Animals; Calcium; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibrosis; Hyperparathyroidism; Kidney; Male; Parathyroid Hormone; Phenethylamines; Polycystic Kidney Diseases; Propylamines; Rats; Rats, Inbred Strains; Receptors, Calcium-Sensing; Severity of Illness Index | 2009 |
Type II calcimimetics and polycystic kidney disease: unanswered questions.
Topics: Aniline Compounds; Animals; Calcium; Calcium Gluconate; Disease Models, Animal; Disease Progression; Male; Phenethylamines; Polycystic Kidney Diseases; Propylamines; Rats | 2009 |
Calcimimetics inhibit renal pathology in rodent nephronophthisis.
Topics: Aniline Compounds; Animals; Calcimimetic Agents; Cell Line; Cell Proliferation; Cyclic AMP; Disease Models, Animal; Female; Humans; Kidney; Kidney Diseases, Cystic; Kinesins; Male; Mice; Mice, Mutant Strains; Mutation, Missense; Phenethylamines; Polycystic Kidney, Autosomal Recessive; Propylamines; Receptors, Calcium-Sensing | 2011 |
Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Topics: Aniline Compounds; Animals; Calcimimetic Agents; Calcium Signaling; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Naphthalenes; Phenethylamines; Propylamines; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; RNA Interference; Spermine; Time Factors; Transfection; Vasoconstriction | 2012 |
Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
Topics: Analysis of Variance; Aniline Compounds; Animals; Base Sequence; Calcium; Disease Models, Animal; Gene Expression Regulation; Immunohistochemistry; Kidney Failure, Chronic; Male; Molecular Sequence Data; Nephrectomy; Parathyroid Glands; Phenethylamines; Probability; Propylamines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Up-Regulation | 2004 |
[Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics].
Topics: Aniline Compounds; Animals; Apoptosis; Calcitriol; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperparathyroidism, Secondary; Male; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing | 2005 |
Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats.
Topics: Acute Disease; Aniline Compounds; Animals; Blood Pressure Determination; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hypotension; Injections, Subcutaneous; Male; Nephrectomy; Phenethylamines; Probability; Propylamines; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sensitivity and Specificity; Sodium; Time Factors; Uremia | 2006 |
Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.
Topics: Aniline Compounds; Animals; Biopsy, Needle; Blood Chemical Analysis; Calcinosis; Calcitriol; Disease Models, Animal; Drug Therapy, Combination; Immunohistochemistry; Male; Nephrectomy; Phenethylamines; Probability; Propylamines; Rats; Rats, Wistar; RNA, Messenger; Sensitivity and Specificity; Survival Rate; Uremia | 2006 |
Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats.
Topics: Albuminuria; Aniline Compounds; Animals; Calcitriol; Calcium; Disease Models, Animal; Glomerular Filtration Rate; Hyperparathyroidism, Secondary; Kidney; Kidney Tubules; Male; Nephrectomy; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing | 2008 |
The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor.
Topics: Aniline Compounds; Animals; Apoptosis; Blood Urea Nitrogen; Body Weight; Calcitriol; Calcium; Cell Division; Creatinine; Disease Models, Animal; Growth Inhibitors; Male; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Renal Insufficiency | 1997 |
Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.
Topics: Aniline Compounds; Animals; Bone and Bones; Bone Density; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Doxorubicin; Humans; Hyperparathyroidism, Secondary; Male; Osteomalacia; Parathyroid Hormone; Phenethylamines; Phosphates; Propylamines; Rats; Rats, Sprague-Dawley; Uremia | 2000 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |